levonorgestrel has been researched along with lynestrenol in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (50.00) | 18.7374 |
| 1990's | 4 (18.18) | 18.2507 |
| 2000's | 3 (13.64) | 29.6817 |
| 2010's | 3 (13.64) | 24.3611 |
| 2020's | 1 (4.55) | 2.80 |
| Authors | Studies |
|---|---|
| Kollman, PA; Lee, DL; Marsh, FJ; Wolff, ME | 1 |
| Andersch, B; Milsom, I; Sundell, G | 1 |
| Li, QG; Nieuweboer, B | 1 |
| Bertina, RM; Gevers Leuven, JA; Hessel, LW; Kluft, C | 1 |
| Grond, AJ; Janssens, AR; Kreuning, J; Kroon, HM; Ruiter, DJ; van Erpecum, KJ | 1 |
| Käär, K; Ruokonen, A | 1 |
| Baumgarten, S; Hammerstein, J; Römmler, A; Schwartz, U | 1 |
| Crona, N; Samsioe, G; Silfverstolpe, G | 1 |
| Colin, C | 1 |
| Bielfeld, P; Conrad, M; Graf, M; Krüssel, JS; Rudolf, K | 1 |
| Graff-Iversen, S; Stensvold, I; Tverdal, A | 1 |
| Casado, ME; Croxatto, HB; Díaz, S; Maturana, X; Miranda, P; Peralta, O; Reyes, MV; Zepeda, A | 1 |
| Graff-Iversen, S; Tonstad, S | 1 |
| Bertrand, J; Jallatte, CS; Renaud, M; Soutoul, JH | 1 |
| Blum, M; Gelernter, I; Werchow, M | 1 |
| Wynn, V | 1 |
| Laine, K; Palovaara, S; Tybring, G | 1 |
| Düsterberg, B; Endrikat, J; Felsenberg, D; Gerlinger, C; Land, K; Mih, E; Schmidt, W | 1 |
| Foldemo, A; Josefsson, A; Lindberg, M; Wiréhn, AB | 1 |
| Laopaiboon, M; Lumbiganon, P; Mol, BW; Sangkomkamhang, US | 1 |
| Almeida, L; Falcão, A; Gama, H; Nunes, T; Soares-da-Silva, P; Vaz-da-Silva, M | 1 |
| Lumbiganon, P; Pattanittum, P; Sangkomkamhang, US | 1 |
2 review(s) available for levonorgestrel and lynestrenol
| Article | Year |
|---|---|
Progestogens or progestogen-releasing intrauterine systems for uterine fibroids.
Topics: Antineoplastic Agents, Hormonal; Female; Humans; Intrauterine Devices, Medicated; Leiomyoma; Leuprolide; Levonorgestrel; Lynestrenol; Medroxyprogesterone Acetate; Menstruation; Premenopause; Progestins; Randomized Controlled Trials as Topic; Tumor Burden; Uterine Neoplasms | 2013 |
Progestogens or progestogen-releasing intrauterine systems for uterine fibroids (other than preoperative medical therapy).
Topics: Adult; Antineoplastic Agents, Hormonal; Bias; Contraceptives, Oral; Desogestrel; Female; Goserelin; Humans; Intrauterine Devices, Medicated; Leiomyoma; Leuprolide; Levonorgestrel; Lynestrenol; Medroxyprogesterone Acetate; Menstruation; Middle Aged; Nandrolone; Norethindrone Acetate; Premenopause; Progestins; Randomized Controlled Trials as Topic; Tumor Burden; Uterine Neoplasms | 2020 |
7 trial(s) available for levonorgestrel and lynestrenol
| Article | Year |
|---|---|
Effects of desogestrel, levonorgestrel and lynestrenol on serum sex hormone binding globulin, cortisol binding globulin, ceruloplasmin and HDL-cholesterol.
Topics: Adolescent; Adult; Carrier Proteins; Ceruloplasmin; Cholesterol, HDL; Clinical Trials as Topic; Contraceptives, Oral, Combined; Desogestrel; Female; Humans; Levonorgestrel; Lynestrenol; Norgestrel; Norpregnenes; Random Allocation; Sex Hormone-Binding Globulin | 1985 |
Does progestogen reduction in oral contraception parallel reduced lipid metabolic effects?
Topics: Adolescent; Adult; Cholesterol; Cholesterol Esters; Clinical Trials as Topic; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Sequential; Dose-Response Relationship, Drug; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Lipids; Lipoproteins; Lynestrenol; Norgestrel; Progestins; Triglycerides | 1982 |
[Controlled studies on the oral administration of progestagens, an antiestrogen and vitamin B6 in the treatment of mastodynias].
Topics: Administration, Oral; Breast Diseases; Clinical Trials as Topic; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Double-Blind Method; Female; Humans; Levonorgestrel; Lynestrenol; Norgestrel; Pain; Pyridoxine | 1982 |
[Regression of functional cysts: high dosage ovulation inhibitor and gestagen therapy has no added effect].
Topics: Adult; Contraceptives, Oral, Combined; Desogestrel; Dose-Response Relationship, Drug; Drug Administration Schedule; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Lynestrenol; Ovarian Cysts; Ovary; Progesterone Congeners; Prospective Studies; Remission, Spontaneous; Retrospective Studies; Treatment Outcome | 1995 |
The effect of ethinyloestradiol and levonorgestrel on the CYP2C19-mediated metabolism of omeprazole in healthy female subjects.
Topics: Adolescent; Adult; Area Under Curve; Aryl Hydrocarbon Hydroxylases; Contraceptives, Oral, Synthetic; Cross-Over Studies; Cytochrome P-450 CYP2C19; Enzyme Inhibitors; Female; Half-Life; Humans; Levonorgestrel; Lynestrenol; Mixed Function Oxygenases; Omeprazole | 2003 |
A 3-year double-blind, randomized, controlled study on the influence of two oral contraceptives containing either 20 microg or 30 microg ethinylestradiol in combination with levonorgestrel on bone mineral density.
Topics: Adult; Bone Density; Collagen; Collagen Type I; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Cysteine Endopeptidases; Dose-Response Relationship, Drug; Double-Blind Method; Erythema Nodosum; Female; Headache; Humans; Levonorgestrel; Lynestrenol; Peptides; Prospective Studies; Respiratory Tract Infections; Treatment Outcome; Vomiting | 2004 |
Effect of eslicarbazepine acetate on the pharmacokinetics of a combined ethinylestradiol/levonorgestrel oral contraceptive in healthy women.
Topics: Administration, Oral; Analysis of Variance; Contraceptive Agents, Female; Cross-Over Studies; Dibenzazepines; Dose-Response Relationship, Drug; Drug Combinations; Female; Humans; Levonorgestrel; Lynestrenol; Time Factors; Voltage-Gated Sodium Channel Blockers | 2013 |
13 other study(ies) available for levonorgestrel and lynestrenol
| Article | Year |
|---|---|
Quantitative relationships between steroid structure and binding to putative progesterone receptors.
Topics: Androstenes; Animals; Guinea Pigs; Humans; Hydroxyprogesterones; Protein Binding; Rabbits; Receptors, Progesterone; Sheep; Steroids; Structure-Activity Relationship | 1977 |
The influence of different combined oral contraceptives on the prevalence and severity of dysmenorrhea.
Topics: Adult; Contraceptives, Oral, Combined; Dysmenorrhea; Ethinyl Estradiol; Female; Follow-Up Studies; Humans; Levonorgestrel; Lynestrenol; Mestranol; Norethindrone; Norgestrel | 1990 |
Radioimmunological determination of levonorgestrel and ethinylestradiol.
Topics: Animals; Contraceptive Agents, Female; Female; Haplorhini; Immune Sera; Levonorgestrel; Liver; Lynestrenol; Norgestrel; Rabbits; Radioimmunoassay; Rats; Rats, Inbred Strains | 1989 |
Effects of two low-dose oral contraceptives on circulating components of the coagulation and fibrinolytic systems.
Topics: Adult; Blood Coagulation; Blood Proteins; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Fibrinolysis; Humans; Levonorgestrel; Lynestrenol; Norgestrel; Plasminogen; Proteins; Sex Hormone-Binding Globulin; Tissue Plasminogen Activator; von Willebrand Factor | 1987 |
Generalized peliosis hepatis and cirrhosis after long-term use of oral contraceptives.
Topics: Adult; Chemical and Drug Induced Liver Injury; Contraceptives, Oral, Synthetic; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Liver; Liver Cirrhosis; Lynestrenol; Norgestrel; Peliosis Hepatis; Radiography; Time Factors | 1988 |
Anti-estrogenic effects of contraceptive progestins on the dynamics of gonadotropin release.
Topics: Adult; Contraceptives, Oral, Combined; Desogestrel; Dose-Response Relationship, Drug; Drug Interactions; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Levonorgestrel; Longitudinal Studies; Luteinizing Hormone; Lynestrenol; Norgestrel; Norpregnenes; Pituitary Gland | 1982 |
Cardiovascular risk factors in Norwegian women using oral contraceptives: results from a cardiovascular health screening 1985-88.
Topics: Adult; Blood Pressure; Cardiovascular Diseases; Contraceptive Agents, Female; Contraceptives, Oral, Synthetic; Coronary Disease; Desogestrel; Estradiol; Female; Health Surveys; Humans; Levonorgestrel; Lipids; Lynestrenol; Middle Aged; Norethindrone; Norway; Progesterone Congeners; Prospective Studies; Risk Factors; Smoking; Surveys and Questionnaires | 1996 |
Fertility regulation in nursing women. IX. Contraceptive performance, duration of lactation, infant growth, and bleeding patterns during use of progesterone vaginal rings, progestin-only pills, Norplant implants, and Copper T 380-A intrauterine devices.
Topics: Adult; Breast Feeding; Chile; Contraception; Contraceptives, Oral, Synthetic; Drug Implants; Female; Follow-Up Studies; Humans; Intrauterine Devices, Copper; Lactation; Levonorgestrel; Lynestrenol; Male; Patient Dropouts; Pregnancy Rate; Progesterone; Reference Values; Time Factors | 1997 |
Use of progestogen-only contraceptives/medications and lipid parameters in women age 40 to 42 years: results of a population-based cross-sectional Norwegian Survey.
Topics: Administration, Oral; Adult; Blood Glucose; Blood Pressure; Body Mass Index; Cardiovascular Diseases; Case-Control Studies; Cholesterol; Cholesterol, HDL; Cross-Sectional Studies; Delayed-Action Preparations; Female; Health Surveys; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Lipoproteins; Lynestrenol; Medroxyprogesterone Acetate; Norethindrone; Norway; Progestins; Risk Factors; Triglycerides | 2002 |
[Comparative study of 4 microdose progestagen - only non-stop oral contraceptives (lynestrenol, D-norgestrel, norethisterone acetate, norgestrienone) on 483 women and 4358 cycles)].
Topics: Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Evaluation Studies as Topic; Family Planning Services; Levonorgestrel; Lynestrenol; Norethindrone; Progesterone Congeners; Research | 1976 |
Effect of oral contraception by progesterone pill on lipids and glucose metabolism.
Topics: Biology; Carbohydrates; Clinical Laboratory Techniques; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Diagnosis; Ethinyl Estradiol; Ethynodiol Diacetate; Family Planning Services; Glucose; Glucose Tolerance Test; Levonorgestrel; Lipids; Lynestrenol; Mestranol; Metabolism; Metrorrhagia; Parity; Physiology; Reproductive Control Agents; Research | 1983 |
[Influence of progestins on adverse effects of oral contraceptives].
Topics: Biology; Carbohydrates; Chemical Phenomena; Chemistry; Cholesterol; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Cyproterone Acetate; Disease; Endocrine System; Ethinyl Estradiol; Ethynodiol Diacetate; Family Planning Services; Glucose; Hormone Antagonists; Hormones; Levonorgestrel; Lipids; Lynestrenol; Metabolism; Norethindrone; Norethynodrel; Norgestrel; Organic Chemicals; Physiology; Reproductive Control Agents | 1985 |
Differences in prescription rates and odds ratios of antidepressant drugs in relation to individual hormonal contraceptives: a nationwide population-based study with age-specific analyses.
Topics: Adolescent; Adult; Age Distribution; Antidepressive Agents; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Desogestrel; Drug Combinations; Drug Utilization; Female; Humans; Levonorgestrel; Logistic Models; Lynestrenol; Medroxyprogesterone; Norgestrel; Odds Ratio; Oximes; Population Surveillance; Practice Patterns, Physicians'; Registries; Sweden | 2012 |